Longitudinal assessment of neurocognitive function in people with relapsing multiple sclerosis initiating alemtuzumab in routine clinical practice: LEM-COG study results-Reference-Cited by-同舟云学术

Longitudinal assessment of neurocognitive function in people with relapsing multiple sclerosis initiating alemtuzumab in routine clinical practice: LEM-COG study results

Published:2023-05 Issue: Volume:73 Page:104677
ISSN:2211-0348
Container-title:Multiple Sclerosis and Related Disorders
language:en
Short-container-title:Multiple Sclerosis and Related Disorders

Author:

Wilken Jeffrey,Traboulsee Anthony,Nelson Flavia,Ionete Carolina,Kolind Shannon,Fratto Timothy,Kane Robert,Gandhi Roopali,Rawlings Andreea M.,Roesch Nora,Ozog Mark A.,DeLuca John

Publisher

Elsevier BV

Subject

Neurology (clinical),Neurology,General Medicine

Reference84 articles.

1. Effects of 2-year treatment with dimethyl fumarate on cognition and functional impairment in patients with relapsing remitting multiple sclerosis;Amato;Neurol. Sci.,2020

2. Comparison of the psychometric properties of two fatigue scales in multiple sclerosis;Amtmann;Rehabil. Psychol.,2012

3. Superior MRI outcomes with alemtuzumab compared with subcutaneous interferon β-1a in MS;Arnold;Neurology,2016

4. Impact of alemtuzumab on health-related quality of life over 6 years in CARE-MS II trial extension patients with relapsing-remitting multiple sclerosis;Arroyo;Mult. Scler.,2020

5. The clinico-radiological paradox in multiple sclerosis revisited;Barkhof;Curr. Opin. Neurol.,2002

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effects of a Remote Multimodal Intervention Involving Diet, Walking Program, and Breathing Exercise on Quality of Life Among Newly Diagnosed People with Multiple Sclerosis: A Quasi-Experimental Non-Inferiority Pilot Study;Degenerative Neurological and Neuromuscular Disease;2024-01

2. Alemtuzumab‐induced petechiae and epistaxis in a patient with relapsing–remitting multiple sclerosis: A case report;Clinical Case Reports;2023-11